Yoo M - Search Results

1

Semi-Automated Cell Panning for Efficient Isolation of FGFR3-Targeting Antibody.

Min B, Yoo M, Kim H, Cho M, Nam DH, Yoon Y. Min B, et al. Among authors: yoo m. Int J Mol Sci. 2021 Jun 9;22(12):6240. doi: 10.3390/ijms22126240. Int J Mol Sci. 2021. PMID: 34207911 Free PMC article.

2

Prognostic Value of Metabolic Tumor Volume on (11)C-Methionine PET in Predicting Progression-Free Survival in High-Grade Glioma.

Yoo MY, Paeng JC, Cheon GJ, Lee DS, Chung JK, Kim EE, Kang KW. Yoo MY, et al. Nucl Med Mol Imaging. 2015 Dec;49(4):291-7. doi: 10.1007/s13139-015-0362-0. Epub 2015 Aug 29. Nucl Med Mol Imaging. 2015. PMID: 26550048 Free PMC article.

3

Tumor-Associated Macrophages Enhance Tumor Hypoxia and Aerobic Glycolysis.

Jeong H, Kim S, Hong BJ, Lee CJ, Kim YE, Bok S, Oh JM, Gwak SH, Yoo MY, Lee MS, Chung SJ, Defrêne J, Tessier P, Pelletier M, Jeon H, Roh TY, Kim B, Kim KH, Ju JH, Kim S, Lee YJ, Kim DW, Kim IH, Kim HJ, Park JW, Lee YS, Lee JS, Cheon GJ, Weissman IL, Chung DH, Jeon YK, Ahn GO. Jeong H, et al. Among authors: yoo my. Cancer Res. 2019 Feb 15;79(4):795-806. doi: 10.1158/0008-5472.CAN-18-2545. Epub 2019 Jan 4. Cancer Res. 2019. PMID: 30610087

4

Noninvasive imaging of radiolabeled exosome-mimetic nanovesicle using (99m)Tc-HMPAO.

Hwang DW, Choi H, Jang SC, Yoo MY, Park JY, Choi NE, Oh HJ, Ha S, Lee YS, Jeong JM, Gho YS, Lee DS. Hwang DW, et al. Sci Rep. 2015 Oct 26;5:15636. doi: 10.1038/srep15636. Sci Rep. 2015. PMID: 26497063 Free PMC article.

5

Efficacy of voxel-based dosimetry map for predicting response to trans-arterial radioembolization therapy for hepatocellular carcinoma: a pilot study.

Yoo MY, Paeng JC, Kim HC, Lee MS, Lee JS, Lee DS, Kang KW, Cheon GJ. Yoo MY, et al. Nucl Med Commun. 2021 Dec 1;42(12):1396-1403. doi: 10.1097/MNM.0000000000001471. Nucl Med Commun. 2021. PMID: 34392298

6

Prognostic value of metabolic tumour volume on baseline ¹⁸F-FDG PET/CT in addition to NCCN-IPI in patients with diffuse large B-cell lymphoma: further stratification of the group with a high-risk NCCN-IPI.

Shagera QA, Cheon GJ, Koh Y, Yoo MY, Kang KW, Lee DS, Kim EE, Yoon SS, Chung JK. Shagera QA, et al. Eur J Nucl Med Mol Imaging. 2019 Jul;46(7):1417-1427. doi: 10.1007/s00259-019-04309-4. Epub 2019 Apr 2. Eur J Nucl Med Mol Imaging. 2019. PMID: 30941463

7

In vivo tissue pharmacokinetics of ERBB2-specific binding oligonucleotide-based drugs by PET imaging.

Park SM, Baek S, Lee JH, Woo SK, Lee TS, Park HS, Lee J, Kang YK, Kang SY, Yoo MY, Yoon HJ, Kim BS, Lee KP, Moon BS. Park SM, et al. Clin Transl Sci. 2023 Jul;16(7):1186-1196. doi: 10.1111/cts.13522. Epub 2023 Apr 20. Clin Transl Sci. 2023. PMID: 37038354 Free PMC article.

8

Parametric Cerebrovascular Reserve Images Using Acetazolamide (99m)Tc-HMPAO SPECT: A Feasibility Study of Quantitative Assessment.

Choi H, Yoo MY, Cheon GJ, Kang KW, Chung JK, Lee DS. Choi H, et al. Nucl Med Mol Imaging. 2013 Sep;47(3):188-95. doi: 10.1007/s13139-013-0214-8. Epub 2013 Jul 16. Nucl Med Mol Imaging. 2013. PMID: 24900106 Free PMC article.

9

Multicentric Primary Angiosarcoma of Bone Mimicking Metastasis on (18)F-FDG PET/CT in a Patient with a History of Sigmoid Colon Cancer: a Case Report.

Yoo MY, Lee ES, Kim SK, Park SY, Kwon Y, Yun T, Kim TS. Yoo MY, et al. Nucl Med Mol Imaging. 2015 Dec;49(4):321-4. doi: 10.1007/s13139-015-0353-1. Epub 2015 Jul 24. Nucl Med Mol Imaging. 2015. PMID: 26550053 Free PMC article.

10

Clinical Usefulness of 18 F-FET PET in a Pediatric Patient With Suspected Demyelinating Disease.

Kang SY, Moon BS, Yoo MY, Yoon HJ, Kim BS. Kang SY, et al. Clin Nucl Med. 2022 Aug 1;47(8):e562-e564. doi: 10.1097/RLU.0000000000004201. Epub 2022 Apr 5. Clin Nucl Med. 2022. PMID: 35384903

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,213 results

Search Page